Department of Obstetrics and Gynecology, The Second Affiliated Hospital of Wenzhou Medical University, No. 109 Xueyuan Xi Road, Wenzhou, 325027, Zhejiang, China.
Center of Scientific Research, The Second Affiliated Hospital of Wenzhou Medical University, Wenzhou, 325027, Zhejiang, China.
Stem Cell Res Ther. 2019 Apr 18;10(1):124. doi: 10.1186/s13287-019-1222-0.
Emerging evidence shows that epithelial-mesenchymal transition (EMT) plays a crucial role in tumor invasion, metastasis, cancer stem cells, and drug resistance. Data obtained thus far have revealed that F-box proteins are critically involved in the regulation of the EMT process and stem cell differentiation in human cancers. In this review, we will briefly describe the role of EMT and stem cells in cell metastasis and drug resistance. We will also highlight how numerous F-box proteins govern the EMT process and stem cell survival by controlling their downstream targets. Additionally, we will discuss whether F-box proteins involved in drug resistance are associated with EMT and cancer stem cells. Targeting these F-box proteins might be a potential therapeutic strategy to reverse EMT and inhibit cancer stem cells and thus overcome drug resistance in human cancers.
新出现的证据表明上皮-间质转化(EMT)在肿瘤侵袭、转移、癌症干细胞和耐药性中起着关键作用。迄今为止获得的数据表明,F -box 蛋白在人类癌症中 EMT 过程和干细胞分化的调节中起着至关重要的作用。在这篇综述中,我们将简要描述 EMT 和干细胞在细胞转移和耐药性中的作用。我们还将强调许多 F-box 蛋白如何通过控制其下游靶标来调节 EMT 过程和干细胞存活。此外,我们将讨论参与耐药性的 F-box 蛋白是否与 EMT 和癌症干细胞相关。针对这些 F-box 蛋白可能是一种潜在的治疗策略,可逆转 EMT 并抑制癌症干细胞,从而克服人类癌症中的耐药性。